FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes. Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn’t rule out increased cancer risk
Oct 10, 2019
The U.S. Food and Drug Administration today authorized the Personal Genome Service Genetic Health Risk...
Dr. Quay recommends participation in clinic trials for all women newly diagnosed with breast cancer. The National Institutes of Health can help you find if one of the over 9,000 studies is right for you.
